+7 (499) 350-59-54

Ideas

Our observations, insights and news from the investment world

What is the probability now of a recession? With employment optimism pitted against inflation pessimism, we look at the odds.
To access this post, you must purchase Subscription Plan – AVC Pro.
A surprising Russian invasion in Ukraine has thrown the world back to a Cold War status. Mid-term election years are when these types of political and economic upheavals usually reveal their ugly heads. Going forward the market will work to find a bottom during a likely volatile year for investors.
To access this post, you must purchase Subscription Plan – AVC Pro.
In mid-term election years, US markets perform generally well in March. Leadership in small caps stocks is discernible.
To access this post, you must purchase Subscription Plan – AVC Pro.
Reports are circulating in the British press that the Home Secretary (UK’s interior Minister) will announce an end to the so-called Golden Visa for UK immigrants. These Visas allowed High Net Worth individuals to buy a fast track to UK residency and ultimately citizenship.
Today's hot CPI numbers burned the market. The Fed's Bullard gets hawkish and may spell problems for the market going forward in February.
To access this post, you must purchase Subscription Plan – AVC Pro.
February has been getting lousier for investors. The first half is usually better than the second. Utilities and High Tech start bullish seasonal trends soon.
To access this post, you must purchase Subscription Plan – AVC Pro.
While the fundamental economic outlook remains positive for US markets, inflation and high stock multiples are wearing on investor sentiment. February could offer a reprieve for the market in the volatile mid-term election year.
To access this post, you must purchase Subscription Plan – AVC Pro.
A little known fact is one of the multitude of variables used by the UK pensions authority to calculate state pension liabilities involve both expected mortality AND the ratio that has on time spent working verses retirement.
AVC have focused on the two leading Biotech ETFs over the last few years, but it has been a tough year. We follow XBI and IBB. XBI is SPDR S&P Biotech, and IBB is iShares Biotechnology.
Mid-Term Januarys usually provide less than optimal market conditions for investors. They also are less prescriptive of the rest of the year's returns.
To access this post, you must purchase Subscription Plan – AVC Pro.
Scroll to Top